ANIK - Anika Therapeutics, Inc.

QQQ $ 452.83 $ 6.97 (1.56 %)

DIA $ 399.31 $ 3.70 (0.94 %)

SPY $ 529.09 $ 6.48 (1.24 %)

TLT $ 92.14 $ 1.24 (1.36 %)

GLD $ 220.89 $ 2.80 (1.28 %)

Previous Close

$ 26.08

Open

$ 26.06

Bid

$ 0.00 x 0

Ask

$ 0.00 x 0

Day's Range

$ 25.59 - $ 26.22

52 Week Range

$ 16.54 - $ 28.67

Volume

51,892

Average Volume

Market Cap

383.32M

Beta (5Y Monthly)

$ 1.03

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	05-08-2024	03-31-2024	10-Q
2	03-15-2024	12-31-2023	10-K
3	11-02-2023	09-30-2023	10-Q
4	08-08-2023	06-30-2023	10-Q
5	05-09-2023	03-31-2023	10-Q
6	03-16-2023	12-31-2022	10-K
7	11-09-2022	09-30-2022	10-Q
8	08-04-2022	06-30-2022	10-Q
9	05-05-2022	03-31-2022	10-Q
10	03-11-2022	12-31-2021	10-K
11	11-04-2021	09-30-2021	10-Q
12	08-05-2021	06-30-2021	10-Q
13	05-07-2021	03-31-2021	10-Q
14	03-05-2021	12-31-2020	10-K
15	11-05-2020	09-30-2020	10-Q
16	08-07-2020	06-30-2020	10-Q
17	05-22-2020	03-31-2020	10-Q
18	03-06-2020	12-31-2019	10-K
19	10-28-2019	09-30-2019	10-Q
20	07-26-2019	06-30-2019	10-Q
21	05-06-2019	03-31-2019	10-Q
22	02-27-2019	12-31-2018	10-K
23	10-26-2018	09-30-2018	10-Q
24	07-31-2018	06-30-2018	10-Q
25	05-10-2018	03-31-2018	10-Q
26	02-27-2018	12-31-2017	10-K
27	10-27-2017	09-30-2017	10-Q
28	07-28-2017	06-30-2017	10-Q
29	05-04-2017	03-31-2017	10-Q
30	02-24-2017	12-31-2016	10-K
31	11-01-2016	09-30-2016	10-Q
32	08-01-2016	06-30-2016	10-Q
33	05-03-2016	03-31-2016	10-Q
34	03-10-2016	12-31-2015	10-K
35	11-03-2015	09-30-2015	10-Q
36	08-04-2015	06-30-2015	10-Q
37	05-04-2015	03-31-2015	10-Q
38	03-13-2015	12-31-2014	10-K
39	11-06-2014	09-30-2014	10-Q
40	08-04-2014	06-30-2014	10-Q

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

Barrington Research Maintains Outperform o...
05/09/2024 16:17:36

Barrington Research analyst Michael Petusky maintains Anika Therapeutics (NASDAQ:ANIK) with a Outperform and maintains $37 p...

Anika Says Cost Reduction Initiatives Comp...
05/08/2024 22:31:43

The Company expects adjusted EBITDA for 2024 to be $25 to $30 million, up over 75% at the midpoint, representing an adjusted EB...

Anika Announces Steve Griffin Appointed To...
05/08/2024 21:56:27

Anika Therapeutics, Inc. (NASDAQ:ANIK), a global joint preservation company in early intervention orthopedics, today announced ...

Anika Therapeutics Q1 2024 Adj EPS $0.09 B...
05/08/2024 20:11:08

Anika Therapeutics (NASDAQ:ANIK) reported quarterly earnings of $0.09 per share which beat the analyst consensus estimate of $(...

Barrington Research Maintains Outperform o...
03/14/2024 14:15:33

Barrington Research analyst Michael Petusky maintains Anika Therapeutics (NASDAQ:ANIK) with a Outperform and raises the pric...

Stephens & Co. Reiterates Equal-Weight on ...
03/14/2024 13:55:13

Stephens & Co. analyst George Sellers reiterates Anika Therapeutics (NASDAQ:ANIK) with a Equal-Weight and maintains $22 ...

Anika Therapeutics: Q4 Earnings Insights
03/13/2024 20:40:17

Anika Therapeutics Q4 2023 Adj EPS $0.05 B...
03/13/2024 20:36:18

Anika Therapeutics (NASDAQ:ANIK) reported quarterly earnings of $0.05 per share which beat the analyst consensus estimate of $(...

Anika Therapeutics Sees FY24 Revenue $168M...
03/13/2024 20:35:45

Fiscal 2024 GuidanceIn 2024, Anika is prioritizing accelerated growth in profitability, with a focus on the products with the g...

Earnings Scheduled For March 13, 2024
03/13/2024 10:15:56

Companies Reporting Before The Bell • Sangamo Therapeutics (NASDAQ:SGMO) is likely to report quarterly loss at $0.26 per share...

Earnings Outlook For Anika Therapeutics
03/12/2024 15:00:45

Barrington Research Maintains Outperform o...
01/03/2024 15:12:16

Barrington Research analyst Michael Petusky maintains Anika Therapeutics (NASDAQ:ANIK) with a Outperform and raises the pric...

Anika Announces First Surgeries Performed ...
11/28/2023 14:36:16

Integrity marks Anika's entrance into the fast-growing $150 million+2 U.S. rotator cuff augmentation market and expansion o...

Barrington Research Maintains Outperform o...
11/03/2023 16:05:08

Barrington Research analyst Michael Petusky maintains Anika Therapeutics (NASDAQ:ANIK) with a Outperform and raises the pric...

Anika Therapeutics Sees FY23 Revenue $164M...
11/02/2023 21:57:45

Anika Therapeutics Q3 Sales $41.47M Beat $...
11/02/2023 21:06:44

Anika Therapeutics (NASDAQ:ANIK) reported quarterly sales of $41.47 million which beat the analyst consensus estimate of $38.27...

Earnings Scheduled For November 2, 2023
11/02/2023 08:56:34

Companies Reporting Before The Bell • AudioCodes (NASDAQ:AUDC) is estimated to report quarterly earnings at $0.18 per share on...

Stocks That Hit 52-Week Lows On Tuesday
09/05/2023 17:34:18

On Tuesday, 164 companies achieved new lows for the year.

Benzinga's Top Ratings Upgrades, Downgrade...
08/14/2023 15:00:31

Barrington Research Upgrades Anika Therape...
08/14/2023 12:46:22

Barrington Research analyst Michael Petusky upgrades Anika Therapeutics (NASDAQ:ANIK) from Market Perform to Outperform and ...